These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37798677)

  • 1. Cognitive impairment indicator for the neuropsychological test batteries in the Canadian Longitudinal Study on Aging: definition and evidence for validity.
    O'Connell ME; Kadlec H; Griffith LE; Wolfson C; Maimon G; Taler V; Kirkland S; Raina P
    Alzheimers Res Ther; 2023 Oct; 15(1):167. PubMed ID: 37798677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methodological considerations when establishing reliable and valid normative data: Canadian Longitudinal Study on Aging (CLSA) neuropsychological battery.
    O'Connell ME; Kadlec H; Griffith LE; Maimon G; Wolfson C; Taler V; Simard M; Tuokko H; Voll S; Kirkland S; Raina P
    Clin Neuropsychol; 2022 Nov; 36(8):2168-2187. PubMed ID: 34470568
    [No Abstract]   [Full Text] [Related]  

  • 3. Validation of the Neuronorma battery for neuropsychological assessment in multiple sclerosis.
    Matías-Guiu JA; Sánchez-Benavides G; Rivera-Àvila N; Cortés-Martínez A; Delgado-Alonso C; Delgado-Álvarez A; Montero P; Pytel V; Matías-Guiu J; Peña-Casanova J
    Mult Scler Relat Disord; 2020 Jul; 42():102070. PubMed ID: 32330845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between shift work exposure and cognitive impairment among middle-aged and older adults: Results from the Canadian Longitudinal Study on Aging (CLSA).
    Khan D; Edgell H; Rotondi M; Tamim H
    PLoS One; 2023; 18(8):e0289718. PubMed ID: 37610977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RAPID-II Neuropsychological Test battery for subjects aged 20 to 49 years: Norms and cognitive profile.
    Binetruy M; Mauny F; Lavaux M; Meyer A; Sylvestre G; Puyraveau M; Berger E; Magnin E; Vandel P; Galmiche J; Chopard G;
    Rev Neurol (Paris); 2018; 174(1-2):44-55. PubMed ID: 28673660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normative Data for the ELSA-Brasil Neuropsychological Assessment and Operationalized Criterion for Cognitive Impairment for Middle-Aged and Older Adults.
    Bertola L; Benseñor IM; Goulart AC; Brunoni AR; Caramelli P; Barreto SM; Giatti L; Salvador L; Griep RH; Moreno AB; Lotufo PA; Suemoto CK
    J Int Neuropsychol Soc; 2021 Mar; 27(3):293-303. PubMed ID: 33050967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity and sensitivity of Canadian normative data for the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) battery.
    Berard JA; Walker LAS
    Mult Scler Relat Disord; 2022 Jul; 63():103865. PubMed ID: 35580469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of cognitive functions in patients with multiple sclerosis applying the normative values of the Rao's brief repeatable battery in the Portuguese population.
    Sousa C; Rigueiro-Neves M; Passos AM; Ferreira A; Sá MJ;
    BMC Neurol; 2021 Apr; 21(1):170. PubMed ID: 33882847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and Normative Data for the Modified Telephone Interview for Cognitive Status: The Sydney Memory and Ageing Study.
    Bentvelzen AC; Crawford JD; Theobald A; Maston K; Slavin MJ; Reppermund S; Kang K; Numbers K; Brodaty H; Sachdev P; Kochan NA
    J Am Geriatr Soc; 2019 Oct; 67(10):2108-2115. PubMed ID: 31290146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric Properties of the National Institute of Neurological Disorders and Stroke and Canadian Stroke Network Neuropsychological Battery in an Asian Older Adult Sample.
    Chew KA; Chong EJY; Chen CLH; Xu X
    J Am Med Dir Assoc; 2020 Jun; 21(6):879-883.e1. PubMed ID: 32444287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive measures in the Canadian Longitudinal Study on Aging.
    Tuokko H; Griffith LE; Simard M; Taler V
    Clin Neuropsychol; 2017 Jan; 31(1):233-250. PubMed ID: 27830627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.
    Harrison JE; Rentz DM; Brashear HR; Arrighi HM; Ropacki MT; Liu E
    J Prev Alzheimers Dis; 2018; 5(4):236-244. PubMed ID: 30298182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An initial exploration of the convergent and ecological validity of the UDS 3.0 neuropsychological battery in Parkinson's Disease.
    Lea R; Benge JF; Adler CH; Beach TG; Belden CM; Zhang N; Shill HA; Driver-Dunckley E; Mehta SH; Atri A
    J Clin Exp Neuropsychol; 2021 Nov; 43(9):918-925. PubMed ID: 35138228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Toronto Cognitive Assessment (TorCA): normative data and validation to detect amnestic mild cognitive impairment.
    Freedman M; Leach L; Carmela Tartaglia M; Stokes KA; Goldberg Y; Spring R; Nourhaghighi N; Gee T; Strother SC; Alhaj MO; Borrie M; Darvesh S; Fernandez A; Fischer CE; Fogarty J; Greenberg BD; Gyenes M; Herrmann N; Keren R; Kirstein J; Kumar S; Lam B; Lena S; McAndrews MP; Naglie G; Partridge R; Rajji TK; Reichmann W; Uri Wolf M; Verhoeff NPLG; Waserman JL; Black SE; Tang-Wai DF
    Alzheimers Res Ther; 2018 Jul; 10(1):65. PubMed ID: 30021658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of cognition short of dementia: Framingham Heart Study and Mayo Clinic Study of Aging.
    Knopman DS; Beiser A; Machulda MM; Fields J; Roberts RO; Pankratz VS; Aakre J; Cha RH; Rocca WA; Mielke MM; Boeve BF; Devine S; Ivnik RJ; Au R; Auerbach S; Wolf PA; Seshadri S; Petersen RC
    Neurology; 2015 Nov; 85(19):1712-21. PubMed ID: 26453643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracking Cognitive Decline in Amnestic Mild Cognitive Impairment and Early-Stage Alzheimer Dementia: Mini-Mental State Examination versus Neuropsychological Battery.
    Kim J; Na HK; Byun J; Shin J; Kim S; Lee BH; Na DL
    Dement Geriatr Cogn Disord; 2017; 44(1-2):105-117. PubMed ID: 28768247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evidence-based approach to the creation of normative data: base rates of impaired scores within a brief neuropsychological battery argue for age corrections, but against corrections for medical conditions.
    O'Connell ME; Tuokko H; Voll S; Simard M; Griffith LE; Taler V; Wolfson C; Kirkland S; Raina P
    Clin Neuropsychol; 2017; 31(6-7):1188-1203. PubMed ID: 28679302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression-Based Norms and Validation of the Cambridge Neuropsychological Test Automated Battery among Community-Living Older Adults in Singapore.
    Siew SKH; Han MFY; Mahendran R; Yu J
    Arch Clin Neuropsychol; 2022 Feb; 37(2):457-472. PubMed ID: 34530442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual Impairment, Eye Disease, and 3-Year Cognitive Decline: The Canadian Longitudinal Study on Aging.
    Grant A; Aubin MJ; Buhrmann R; Kergoat MJ; Li G; Freeman EE
    Ophthalmic Epidemiol; 2022 Oct; 29(5):545-553. PubMed ID: 34486480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normative data for the 10/66 dementia research group neuropsychological test battery from Singapore's older adult population.
    Cetty L; Peh CX; Abdin E; Vaingankar JA; Shahwan S; Picco L; Prince M; Chong SA; Subramaniam M
    Asian J Psychiatr; 2020 Jun; 51():102019. PubMed ID: 32251896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.